HU Man-li, DENG Hong-yan, FU Jie, et al. Tangmaikang Particles to Glucose Fluctuation of Patients with Type Two Diabetes Mellitus[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(14): 173-176.
HU Man-li, DENG Hong-yan, FU Jie, et al. Tangmaikang Particles to Glucose Fluctuation of Patients with Type Two Diabetes Mellitus[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(14): 173-176. DOI: 10.13422/j.cnki.syfjx.2015140173.
Objective: The aim of this study was to siscuss the influence of Tangmaikang particles on glucose fluctuation and impact on oxidative stress
and the function of vascular endothelium in treating type-two diabetes mellitus (T2DM). Method: Two hundred and thirty patients with T2DM were randomly divided into control group and observation group by random number table.Patients in control group received repaglinide tablets.Based on the treatment of control group
patients in observation group were added Tangmaikang particles.Before and after treatment
continuous glucoses including standard deviation of blood glucose level (SDBG)
mean amplitude of glycemic excursions (MAGE)
mean of daily differences (MODD)
and mean postprandial glucose excursion (MPPGE)were monitored;and fasting blood-glucose (FBG)
fasting insulin(FINS)
two hours' postprandial blood glucose (2 hPBG) and glycosylated hemoglobin (HbA1c)were detected
and indexes of homeostasis model assessment of insulin resistance (HOMA-IR)
secretion function of pancreas islet B cell and insulin sensitivity(ISI) were calculated.The serum triglyceride (TG)
total cholesterol (TC)
high density lipoprotein (HDL-C)
and low density lipoprotein (LDL-C) were measured. Result: After treatment
indexes of SDBG
MAGE
MODD
MPPGE
HOMA-IR FBG
2 hPBG
HbA1c
TG
TC and LDL-C in observation group were all lower than those in control group
but the indexes of HOMA-IS and ISl were higher than those in control group (P<0.05). Conclusion: Tangmaikang particles can reduce blood glucose of patients with T2DM